“the natural way to better health”  
Natural Nutritional Products

LB17 - LIVE probiotic

Free Radical Test Kit

Heavy Metals Test Kits

Flax Hulls - Lignans & Sulforaphane

VitaC plus - ester-C anti-aging anti-wrinkle green tea based serum

Heavy Metals Detox

10-P Urine Analysis

pH Indicator


Heavy Metal Test kits

Other Self Test
Free Radical Test
Water Test (2-test pack)
Adrenal Function (Koenigsburg) Test
Calcium (Sulkowitch) Test
pH Test


Heavy Metals Detox

MF (metal free) Water

Eldon Blood Type Test


Practitioner Registration

Strategic Health Markers
Energy
pH State
Free Radicals
Inflammation

 



New Therapies for Psoriasis

Laureen Neergaard
Associated Press - reported in C-Health News


November 4, 2003


It's a new era for patients covered in the itchy, scaly skin disease psoriasis. After years with few good treatments, doctors finally have a handful of therapies that promise to help control the incurable condition with fewer bad side effects.

What changed? Scientists learned that psoriasis isn't just a skin-deep disorder but a dysfunction of the immune system, so the new therapies target the real culprit (see below).

"Five to six years ago, I was telling my patients it was the wasteland," says Dr. Craig Leonardi of St. Louis University Medical School, who participated in studies of the new treatments. "Now there's this huge explosion of amazing drugs coming forward."

The new options don't help everyone, cautions Dr. Michael Tharp, dermatology chief at Chicago's Rush University Medical Center. And they're very expensive, costing $10,000 a year or more.

But, "it's a great first step," Tharp says. "Now we've got very directed molecules and know where they work and how they work. ... I hope it is just the beginning."

Two unique psoriasis shots, Amevive and Raptiva, recently won Food and Drug Administration approval. Two drugs already sold to treat other conditions -- Enbrel and Remicade -- are used against psoriasis, too. A list of other potential treatments is under study.

The four newest options haven't yet been compared to each other, but because each works somewhat differently, specialists expect hard-to-treat patients to find some relief among the bunch.

Some 4.5 million Americans have psoriasis. Of those, 1.5 million suffer moderate to severe symptoms -- their skin covered in red or white scaly patches that burn and itch. It's triggered when certain immune system cells, called memory effector T cells, run amok, causing skin cells to multiply faster than normal and become inflamed.

It can be life-altering.

"I wouldn't wear anything but long-legged pants and long-sleeved shirts because I got so tired of people asking me questions," says Lyle Newcomb, 60, of Milwaukie, Ore., who tried every treatment without success. "You don't allow yourself to get real close to anybody because you don't know how they're going to accept it."

Then Newcomb entered a study of Raptiva. "I had never been clear of psoriasis in my life, but I was totally clear in three weeks," and, two years later, weekly shots keep symptoms at bay.

Ointments and light therapy -- ultraviolet beams, sometimes with light-sensitizing drugs, a few times a week -- are effective for milder psoriasis.

Until now, severely hit patients had two powerful options, each with serious side effects. The immune suppressor cyclosporine, commonly used to prevent rejection of transplanted organs, can destroy kidneys. Inflammation-suppressing methotrexate, also used for cancer and rheumatoid arthritis, can cause liver damage.

The new biologically engineered treatments promise more targeted therapy without those risks:

--Amevive and Raptiva interfere with the harmful T cells, dramatically clearing psoriasis lesions in 20 percent to 40 percent of patients.

Amevive causes those T cells to die, explaining why some people's symptoms don't return for months after a three-month course of weekly shots. About 3,500 patients have begun Amevive since FDA approval in January, says maker Biogen Inc. The intramuscular shots are given in a doctor's office.

In contrast, Raptiva keeps harmful immune cells from getting into and inflaming skin, so patients must take it indefinitely. Sales will begin by Thanksgiving, say makers Genentech Inc. and Xoma Ltd. Patients give themselves weekly under-the-skin shots.

That difference means more than convenience; some insurance pays for in-office therapy but not at-home drugs.

--Instead of targeting T cells, Enbrel and Remicade inhibit a protein, TNF, that's crucial to inflammation. FDA-approved for certain types of arthritis, some doctors already use the drugs for psoriasis' skin lesions. The FDA now is evaluating Enbrel injections for that use; a final-stage study of intravenous Remicade is about to begin.

Specialists call the four new treatments largely safe but acknowledge that even mildly tinkering with the immune system for years might spur infections or cancer. "We're crossing our fingers," Tharp says.

That plus their huge cost means the new drugs are reserved for the worst patients. For less severe psoriasis sufferers, "we're back in the stone ages," Tharp says, urging companies to study better options for them, too.

Treatment Strategy
Support Psoriasis treatment by boosting your immune system with a nutritional therapy comprising of LB17 live probiotic and Natural Concentrated Flax Hulls



Comments from healthcare professionals who have used LB17:

Canada
"... I have been using different probiotic blends over the years. The best I found by far is LB17. The ... more strands of different friendly bateria, the better the probiotic. It has been my experience that LB17 covers every area of body fluids from the sinuses to the reproductive organs which give LB17 a great advantage over any other probiotic. My patients love the small size of the capsules and I have used LB17 with great success on open wounds and stubborn acne by ... applying ... directly to the wound.

... be happy to recommend LB17 to any health practitioner."..
Dr. A.W. Martin DC, Ph.D., RNCP, D.N.M.
(November 2007)
Dr Martin is a practising nutritionist in Sudbury Ontario with a PhD in nutrition.

United Kingdom
"I am a Holistic Therapy Practitioner in the UK .......

Finally, I want to make it clear that I am extremely pleased with the benefits that this product LB17 provides for myself and my clients and friends who all wish to purchase more of it..."

Ms Helen Rushforth B.A.(Hons), M.A., Flintshire, North Wales, UK
(May 2008)
Ms Helen Rushforth is a practising healthcare professional in North Wales, UK



Below is an image of a box of LB17 live probiotic and vegetable soft gel capsule
   
Each box contains 60 capsules


LB17 live probiotic biomass
LB17 is now also available in paste form without capsules for those who do not or cannot take capsules - see below

   
Above is a 50gm bottle of LB17 biomass. Next pic is image of the biomass in bulk paste form




The above information is provided for general educational purposes only. It is not intended to replace competent health care advice received from a knowledgeable healthcare professional. You are urged to seek healthcare advice for the treatment of any illness or disease.
Health Canada and the FDA (USA) have not evaluated these statements. This product is not intended to diagnose, treat, cure, or prevent any disease.



 Distributors - Nth America | Sth America | Asia | Europe | Africa | Oceania | Terms & Conditions | Private Policy |  CONTACT
Copyright 2001-2017 Osumex USA Inc. All rights reserved.